Benign Disease

Started by xrt123
This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
Get help with your application

Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.


I liked this document overall. However, the cancer risk discussion is over the top in my opinion. It would be strengthened with discussion and education of BEIR and ICRP risk modeling and guidance. Specifically, that you cannot really model an individual's cancer risk at all, and you should not even try for exposures less than 25 mSv (their hand example was 13 mSv).

Physicists have done a lot of work on this over decades and it feels a bit like fear mongering when this work is not discussed.

The comment about shielding the testicles in a hip case makes little sense for patients >50 when juxtaposed with the rest of our practices in oncology.

I understand the idea that some may ignore ALARA or the principles of quality radiation planning and delivery because its "only 3 Gy".

But I think some of these folks are missing the "reasonably" part of ALARA.
 
Advertisement - Members don't see this ad

I am not convinced of the "risk" of treating the spine unless "someone" knows something they are not telling the rest of us...

I am very skeptical. Every document/white paper that mentions this refers to a paper about treating ankylosing spondylitis with an open field - AP - PA to a dose of 20 Gy in 5 fx, just blasting away probably with cobalt in the 1960s.

We are talking about 3 Gy in 6 Fx with a linear accelerator given qOD to limited fields.

Even though there is no documented 2ndary malignancy in the literature of patients treated with LDRT, for some reason the cabal of "experts" has made spine treatment an unforgiveable sin.

I was definitely treating in the past, but I'm now going to hold off, even though it appears to have same efficacy as other sites.

This plus the 3D volumes .. I don't know. This whole thing is turning so "rad onc". I think I liked it when it was me and Beckta and Mudit and others doing this because it was a cool new treatment to offer. Rather than turn it into whatever it has become with paid training, webinars, lectures, consultancies and guidelines. It's all just made up. The Germans were treating to a point before. I have no idea why we are going nuts trying to "spare medial compartment" blah blah blah. It's 3 Gy in 6 Fx. Don't be cute. Treat the joint and surrounding tissues. Use the old plain film diagrams.

People are doing FLAME boost and ablative pancreas SBRT / hypofrac without paying someone money to learn how to do it. One of the best things about this field is I could read about a technique, email Chris Crane or the Dutch guys who did the microboost study and learn how to do it. No accreditation for this, but now there are people going around accrediting giving a joint 3 Gy? What a world!

Happy Father's Day
 

I am not convinced of the "risk" of treating the spine unless "someone" knows something they are not telling the rest of us...
This whole thing is turning so "rad onc".

Spot on lol.

I would guess if you treated all comers with a prior diagnosis of OA and complaint of pain, hands and knees would have a better efficacy rate than spine. In my experience, spine pain is just a lot more often multifactorial with "non-inflammatory contributions" to the pain. I do offer it, but less often, and sometimes as a last resort with lower expectations of success.

Spine is "numerically riskier" than hands and knees with all the caveats of secondary malignancy modeling, but all of the risk is very low. Its still a reasonable treatment to offer the right patient.

OA researchers are starting to characterize OA phenotypes that may have differential response to treatments. Its an interesting literature, not ready for clinic prime time.

Seems like a better way to personalize treatment than treating isolated joint compartments.
 
I offer LDRT to all comers in all joints. Spine/shoulders/knees/hands/ankles/hips you name it. Complete nonsense to try and say the spine shouldn't be treated. Is there a lower chance it will work? Seems that way from the data. Is the chance zero? No. However, the chance of side effects or 2nd malignancy is super close to zero, so the therapeutic ratio is significantly in the favor of RT.

I'm not surprised at all that the radonc powers that be overcomplicated this by an order of magnitude. Academic radonc has a massive "forest for the trees" problem and always has.
 
I am very skeptical. Every document/white paper that mentions this refers to a paper about treating ankylosing spondylitis with an open field - AP - PA to a dose of 20 Gy in 5 fx, just blasting away probably with cobalt in the 1960s.

We are talking about 3 Gy in 6 Fx with a linear accelerator given qOD to limited fields.

Even though there is no documented 2ndary malignancy in the literature of patients treated with LDRT, for some reason the cabal of "experts" has made spine treatment an unforgiveable sin.

I was definitely treating in the past, but I'm now going to hold off, even though it appears to have same efficacy as other sites.

This plus the 3D volumes .. I don't know. This whole thing is turning so "rad onc". I think I liked it when it was me and Beckta and Mudit and others doing this because it was a cool new treatment to offer. Rather than turn it into whatever it has become with paid training, webinars, lectures, consultancies and guidelines. It's all just made up. The Germans were treating to a point before. I have no idea why we are going nuts trying to "spare medial compartment" blah blah blah. It's 3 Gy in 6 Fx. Don't be cute. Treat the joint and surrounding tissues. Use the old plain film diagrams.

People are doing FLAME boost and ablative pancreas SBRT / hypofrac without paying someone money to learn how to do it. One of the best things about this field is I could read about a technique, email Chris Crane or the Dutch guys who did the microboost study and learn how to do it. No accreditation for this, but now there are people going around accrediting giving a joint 3 Gy? What a world!

Happy Father's Day
Wasn’t there an academic rad onc that used to tell you RT for OA was “scammy”
 
I offer LDRT to all comers in all joints. Spine/shoulders/knees/hands/ankles/hips you name it. Complete nonsense to try and say the spine shouldn't be treated. Is there a lower chance it will work? Seems that way from the data. Is the chance zero? No. However, the chance of side effects or 2nd malignancy is super close to zero, so the therapeutic ratio is significantly in the favor of RT.

I'm not surprised at all that the radonc powers that be overcomplicated this by an order of magnitude. Academic radonc has a massive "forest for the trees" problem and always has.
I agree with you. What is different in the spine, IMHO, is:
- the range of possible diagnoses is greater than in joints. Osteochondrosis intervertebralis, Disc Protrusion/Herniation, Facet Joint Syndrome, Spondylosis, Spinal Stenosis due to thickened ligaments, ... With many patients having a combination of these pathologies, so that even LDRT may work for one, it won't relieve symptoms caused by others.
- how symptoms may be projected. A pathology at one level can cause symptoms on another level.
 
We give 50-60/5 to unbiopsied lung tumors. We radiate 75% of older women with breast cancer to marginally decrease recurrence.
*We irradiate 😉

The number needed to treat for any benefit for old women with favorable risk breast cancer is in the neighborhood of ten.

The NNT for “spine OA” in my experience is about two.

Also I can’t practically tangibly tell who I help or not with the breast RT, but often I can tell with the spine RT. “Job satisfaction” and all that.
 
But we try stuff empirically or minimal benefit all the time in medicine and even in RadOnc

We give 50-60/5 to unbiopsied lung tumors. We radiate 75% of older women with breast cancer to marginally decrease recurrence. We treat bone mets with RT with zero RCTs against placebo or sham RT.

This is a weird restriction

not good examples as a counter argument IMO.

all of these have a benefit, even if marginal in the case of elderly women with breast cancer.

example Palex is talking about is a situation in which there is a question about the nature of the problem, only one of which responds to RT.
 
not good examples as a counter argument IMO.

all of these have a benefit, even if marginal in the case of elderly women with breast cancer.

example Palex is talking about is a situation in which there is a question about the nature of the problem, only one of which responds to RT.
Fair

But the bone mets is similar

No data. But we see it work with our own eyes
 
not good examples as a counter argument IMO.

all of these have a benefit, even if marginal in the case of elderly women with breast cancer.

example Palex is talking about is a situation in which there is a question about the nature of the problem, only one of which responds to RT.
Adjuvant RT has no benefit in 8-9 out of the 10 women who get it. I don't know as much about the odds of a response if we indiscriminately irradiated the spines of patients with pain, but I wouldn't be surprised if higher. I'm sure the durability is higher with breast RT, but as Wallnerus said, it's a decently high NNT.
 
Adjuvant RT has no benefit in 8-9 out of the 10 women who get it. I don't know as much about the odds of a response if we indiscriminately irradiated the spines of patients with pain, but I wouldn't be surprised if higher.

yeah true

but I guess at least I know they have cancer.

idk I dont have a strong opinion on it and I dont see it as a contraindication at all. I have not seen or read directly what was said, but if someone is saying 'have caution in spine' I think it's fine? it's not a rule. its not bad IMO to have some rigor around reporting and guidelines for this. some people wont treat without guidelines or some sort of support from some sort of authority whether it be society support or similar.

all of that coming over the past few years is why so many more people are treating. thats net benefit for patients and for the field. So I dont see it as a bad thing that it's no longer 'rogue' to offer IMO.
 
Advertisement - Members don't see this ad
yeah true

but I guess at least I know they have cancer.

idk I dont have a strong opinion on it and I dont see it as a contraindication at all. I have not seen or read directly what was said, but if someone is saying 'have caution in spine' I think it's fine? it's not a rule. its not bad IMO to have some rigor around reporting and guidelines for this. some people wont treat without guidelines or some sort of support from some sort of authority whether it be society support or similar.

all of that coming over the past few years is why so many more people are treating. thats net benefit for patients and for the field. So I dont see it as a bad thing that it's no longer 'rogue' to offer IMO.
That's the thing, though. Most of them don't (all the **** the wallnerus will post about positive bone marrow biopsies notwithstanding). I say this as i sit here contouring a left breast in a 70 yo who at least had the decency to have triple negative disease (doing 5 fx sib btw.)
 
yeah true

but I guess at least I know they have cancer.

idk I dont have a strong opinion on it and I dont see it as a contraindication at all. I have not seen or read directly what was said, but if someone is saying 'have caution in spine' I think it's fine? it's not a rule. its not bad IMO to have some rigor around reporting and guidelines for this. some people wont treat without guidelines or some sort of support from some sort of authority whether it be society support or similar.

all of that coming over the past few years is why so many more people are treating. thats net benefit for patients and for the field. So I dont see it as a bad thing that it's no longer 'rogue' to offer IMO.

Here is their case discussion in the AUC.

I think payors will jump on the exceptional circumstances language and use it to deny approval. I think this table is overly conservative and not in line with the risk modeling principles they use for other anatomic sites.

This is totally the latest example of "rad onc being weird". Not surprising, especially given some of these folks COI, but I do think the frustration with the opining on this specific type of case is valid.
1782253613626.png
 
got it thanks.

I get it. but also - I feel like this is focusing one one small part of it when to me the bigger point and victory is that this even exists, when this would have been totally out of the realm of possibilities just a few years ago!

I have looked through the ARS AUC guidelines before. often they will include cases of 'NO' so I am sure they specifically designed this question for a no. I think the no makes all the other 'yeses' stronger.

again I think the net benefit of this document FAR outweighs this one nitpick.


just my opinion.

Also I think some people worry too much. Please come post here if a payer cites th as guidelines to refuse your planned lumbar spine RT
 
got it thanks.

I get it. but also - I feel like this is focusing one one small part of it when to me the bigger point and victory is that this even exists, when this would have been totally out of the realm of possibilities just a few years ago!

I have looked through the ARS AUC guidelines before. often they will include cases of 'NO' so I am sure they specifically designed this question for a no. I think the no makes all the other 'yeses' stronger.

again I think the net benefit of this document FAR outweighs this one nitpick.


just my opinion.

Also I think some people worry too much. Please come post here if a payer cites th as guidelines to refuse your planned lumbar spine RT
It’s less to me issue of getting reimbursed.

If the only national guide line says hell no, I don’t think I’m going to do it.

They just aren’t making an evidence based decision, IMO
 
Here is their case discussion in the AUC.

I think payors will jump on the exceptional circumstances language and use it to deny approval. I think this table is overly conservative and not in line with the risk modeling principles they use for other anatomic sites.

This is totally the latest example of "rad onc being weird". Not surprising, especially given some of these folks COI, but I do think the frustration with the opining on this specific type of case is valid.
View attachment 421171
What radiation guideline writers never seem to realize is that it is very hard to unf*ck a pig. Bringing ankylosing spondylitis into the argument was very porcine.
 
Here is their case discussion in the AUC.

I think payors will jump on the exceptional circumstances language and use it to deny approval. I think this table is overly conservative and not in line with the risk modeling principles they use for other anatomic sites.

This is totally the latest example of "rad onc being weird". Not surprising, especially given some of these folks COI, but I do think the frustration with the opining on this specific type of case is valid.
View attachment 421171
A patient may very well accept the risk of secondary malignancy, which is probably much lower than the risk of death from NSAIDS.
 
got it thanks.

I get it. but also - I feel like this is focusing one one small part of it when to me the bigger point and victory is that this even exists, when this would have been totally out of the realm of possibilities just a few years ago!
This part is 100% right. It overall helps us a lot. Lower back was maybe 10% of patients, but there is no shortage of DJD to make up for it. It’s just how hard you want to go. I’m at times overwhelmed by it. I’d way rather see cancer patients.
 
They should have made a case with a more clear reason to say no to, this was just bad design and too broad with the ultimate no. I agree with that

How about an obese 35 year old who responds a little to corticosteroid and would be eligible for replacement with some weight loss.

Not an uncommon case. I've been sent this patient a few times. Even better for teaching, someone that hasn't tried physical therapy.

I think the AUC is fine and Im not worried about anything. My only real gripe is just like why does rad onc gotta be so weird. Just please stop being weird.

I dont think you need a "no" case. That seems like a weird rad onc thing.

There are other guidelines you can look at to compare to see my opinion of not weird, pain society for steroid injections or rheum for OA.
 
How about an obese 35 year old who responds a little to corticosteroid and would be eligible for replacement with some weight loss.
Wonder if possible to discuss the toxicity of a $100K spine surgery (and recovery time, risks, etc) vs the toxicity of second malignancy risk and hematopoietic risk of $3K spine LDRT. I wonder.
 
Advertisement - Members don't see this ad
1st pt I ever treated for arthritis came in for followup this week.

She is 8.5 yrs out from postmastectomy XRT.

She had miserable knee pain severely aggravated by endocrine therapy.

Now 3.5 yrs out from arthritis XRT and has "no pain whatsoever" in her knees. Still on endocrine therapy.
Saw her in f/u again recently. Now almost 7 years out and still no pain in the knees.
 
Interesting Rx

Have people on here been treating with higher doses than 0.5 Gy x6 or altering the Rx for different clinical considerations?
I wish we could just have some godamn stability in LDRT for OA dosing, especially when data suggesting 1Gy x 6 may not show signal, but 0.05Gy x 6 and 0.5Gy x 6 both seem efficacious.
 
I wish we could just have some godamn stability in LDRT for OA dosing, especially when data suggesting 1Gy x 6 may not show signal, but 0.05Gy x 6 and 0.5Gy x 6 both seem efficacious.
It’s the whole is this effect real and not placebo thing. Long term followup from another RCT helps with this but is not the most common/standard dosing! Clarifying the biological effect range would be nice. But also if it works it works… 🤷‍♂️
 
Advertisement - Members don't see this ad